MedPath

BIOINTEGRATOR, OOO

BIOINTEGRATOR, OOO logo
🇷🇺Russia
Ownership
Private
Established
2010-10-28
Employees
1
Market Cap
-
Website
http://www.biointegrator.com

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)

Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab

Phase 1
Terminated
Conditions
Metastatic Breast Cancer
Interventions
First Posted Date
2017-02-23
Last Posted Date
2019-07-16
Lead Sponsor
Biointegrator LLC
Target Recruit Count
6
Registration Number
NCT03062007
Locations
🇷🇺

3. State Medical Preventive Institution "Kirov Region Clinical Oncological Dispensary", Kirov, Russian Federation

🇷🇺

5. State Budgetary Public Healthcare Institution "Leningrad Region Oncological Dispensary", department of surgery, Leningrad Region Settlement Kuz'molovsky, Russian Federation

🇷🇺

2. Moscow State Public Healthcare Institution "Moscow City Oncological Hospital #62 of the Moscow Public Healthcare Department", Moscow Region, Krasnogorsk district, settlement Istra, Russian Federation

and more 3 locations

Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera®

Phase 1
Terminated
Conditions
Rheumatoid Arthritis
Interventions
Drug: Ritumax®
First Posted Date
2017-02-23
Last Posted Date
2019-07-19
Lead Sponsor
Biointegrator LLC
Target Recruit Count
8
Registration Number
NCT03061838
Locations
🇷🇺

Federal State Budgetary Institution "Scientific Research Institution of Rheumatology" Russian Academy of Medical Sciences (FSBI "SRIR" RAMS), Moscow, Russian Federation

Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim

Phase 1
Completed
Conditions
Lymphoma, Non-Hodgkin
Lymphoma, Follicular
Interventions
First Posted Date
2017-02-20
Last Posted Date
2017-05-23
Lead Sponsor
Biointegrator LLC
Target Recruit Count
7
Registration Number
NCT03057418
Locations
🇷🇺

State Budgetary Public Healthcare Institution of the Nizhni Novgorod Region "Hospital of Ambulance of Dzerzhinsk city", Dzerzhinsk, Russian Federation

🇷🇺

Federal State Budgetary Institution "National Medical-Surgical Center n.a. N.I.Pirogov" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation

🇷🇺

Federal State Budgetary Institution "Russian Oncological Scientific Center n.a. N.N.Blokhin" of the Russian Academy of Medical Sciences, Moscow, Russian Federation

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.